Jump to content
RemedySpot.com

Tekmira and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus

Rate this topic


Guest guest

Recommended Posts

Tekmira and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus

From the PharmaLive.com News Archive - Sep. 14, 2011

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference

(RNAi) therapeutics, announced today a presentation of data demonstrating, for

the first time, in vivo efficacy of RNAi against the Hepatitis C virus (HCV).

Link to comment
Share on other sites

Tekmira and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus

From the PharmaLive.com News Archive - Sep. 14, 2011

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference

(RNAi) therapeutics, announced today a presentation of data demonstrating, for

the first time, in vivo efficacy of RNAi against the Hepatitis C virus (HCV).

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...